Combination of the Immune Modulator Dimethyl Fumarate With Alteplase in Acute Ischemic Stroke
Condition(s):Acute Ischemic StrokeLast Updated:June 6, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Acute Ischemic StrokeLast Updated:June 6, 2022Recruiting
Condition(s):Relapsing Forms of Multiple SclerosisLast Updated:March 21, 2017Completed
Condition(s):Multiple SclerosisLast Updated:November 15, 2023Recruiting
Condition(s):Multiple Sclerosis, Relapsing-RemittingLast Updated:June 15, 2023Terminated
Condition(s):Relapsing-Remitting Multiple Sclerosis; Multiple SclerosisLast Updated:March 19, 2020Completed
Condition(s):Multiple SclerosisLast Updated:May 5, 2017Terminated
Condition(s):Multiple Sclerosis, Relapsing-RemittingLast Updated:November 22, 2019Completed
Condition(s):HealthyLast Updated:January 9, 2015Completed
Condition(s):Intracerebral HemorrhageLast Updated:October 25, 2023Withdrawn
Condition(s):Relapsing Remitting Multiple SclerosisLast Updated:October 31, 2019Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.